Showing all 14 results
-
Add to cartSpecification Details Product Name Alluvi Retatrutide 20mg Active Ingredient Retatrutide (LY3437943) Concentration 20mg per vial Mechanism of Action Triple Agonist (GLP-1, GIP, and Glucagon Receptors) Primary Indication Advanced Chronic Weight Management & Metabolic Support Administration Route Subcutaneous Injection Storage Requirements Refrigerate at 2°C to 8°C; protect from direct sunlight -
Add to cartProduct Profile Specifications Product Name BPC157 & TB500 40mg Injection Pen Kit Active Composition Body Protection Compound-157 (20mg) + Thymosin Beta-4 / TB-500 (20mg) Total Blend Strength 40mg per Kit Delivery Mechanism Prefilled, adjustable multi-dose injection pen Purity Grade Pharmaceutical grade (>99% HPLC verified) Primary Applications Advanced tissue regeneration, anti-inflammation, muscle repair, joint healing Storage Requirements Refrigerate at 2°C–8°C after reconstitution -
Add to cartProduct Parameter Details Product Name Mounjaro 12.5mg Active Ingredient Tirzepatide (12.5 mg per 0.6 mL dose) Drug Class GIP and GLP-1 Receptor Agonist (Dual Incretin Mimetic) Primary Indication Chronic Weight Management & Type 2 Diabetes Treatment Administration Route Subcutaneous Injection (Once-Weekly) Manufacturer Eli Lilly Storage Requirements Refrigerate between 2°C to 8°C; Do not freeze -
Add to cartAttribute Specification Brand Name Mounjaro Active Ingredient Tirzepatide Dosage Strength 7.5mg / 0.5mL Medication Class GIP and GLP-1 Receptor Agonist Administration Route Subcutaneous Injection (Once-Weekly) Primary Indication Chronic Weight Management & Type 2 Diabetes Manufacturer Eli Lilly Packaging Variant Pre-filled KwikPen / Single-dose Vials Storage Temperature Refrigerated at 2°C to 8°C (Do not freeze) -
Add to cartFeature Specification Product Name Mysimba Active Ingredients Naltrexone hydrochloride (8 mg) / Bupropion hydrochloride (90 mg) Dosage Form Prolonged-release tablets Primary Indication Chronic weight management in adults Mechanism Targets central nervous system pathways regulating food intake and energy expenditure Manufacturer Central Medical Supplies / Approved European Distributors -
Add to cartSpecification Product Details Product Name Ozempic 0.5mg Pre-filled Pen Active Ingredient Semaglutide (GLP-1 receptor agonist) Strength / Dosage 0.5mg per maintenance dose Primary Indication Type 2 Diabetes Mellitus management Secondary Benefits Weight management support, cardiovascular risk reduction Administration Route Subcutaneous injection (Once-weekly) Storage Requirements Refrigerate new pens ($2^\circ\text{C} – 8^\circ\text{C}$). In-use pens store below $30^\circ\text{C}$ for up to 56 days. Manufacturer Novo Nordisk -
Add to cartFeature Specification Product Name Saxenda 6mg/mL (1 pre-filled pen) Active Ingredient Liraglutide (GLP-1 receptor agonist) Total Volume per Pen 3 mL solution Total Active Substance 18 mg of Liraglutide per pen Available Doses 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg, and 3.0 mg Administration Route Subcutaneous injection (Once daily) Storage Conditions Store in a refrigerator ($2^\circ\text{C} – 8^\circ\text{C}$); do not freeze. -
Add to cartSpecification Product Details Product Name Saxenda 6mg/mL Solution for Injection in a Pre-filled Pen Active Ingredient Liraglutide (GLP-1 receptor agonist) Strength / Concentration 6mg/mL (Each 3mL pen contains 18mg of Liraglutide) Pack Size 5 Pre-filled disposable pens per box Manufacturer Novo Nordisk Primary Indication Chronic Weight Management / Obesity Intervention Administration Route Subcutaneous Injection (Daily) Storage Requirements Refrigerate ($2^\circ\text{C} – 8^\circ\text{C}$) before first use; store below $30^\circ\text{C}$ or in the fridge after activation. -
Add to cartSpecification Details Product Name Semaglutide 8mg Injection Pen Kit Active Ingredient Semaglutide ($8\text{ mg}$ total per pen) Therapeutic Class GLP-1 Receptor Agonist (Glucagon-Like Peptide-1) Delivery System Multi-dose pre-filled injection pen mechanism Primary Indication Chronic weight management and metabolic regulation Route of Administration Subcutaneous injection (abdomen, thigh, or upper arm) Storage Requirements Refrigerate ($2^\circ\text{C}$ to $8^\circ\text{C}$) before use; do not freeze -
Add to cartFeature Specification Product Name Wegovy 3-Month Starter Bundle Pack Active Ingredient Semaglutide (GLP-1 receptor agonist) Included Dosages 0.25 mg, 0.5 mg, and 1.0 mg Supply Duration 12 Weeks (3 Months consecutive treatment) Administration Route Subcutaneous injection (Once weekly) Storage Conditions Refrigerate ($2^\circ\text{C} – 8^\circ\text{C}$), do not freeze Primary Indication Chronic weight management alongside lifestyle changes -
Add to cartFeature Details Product Name Wegovy Maintenance Pack Bundle Active Ingredient Semaglutide ($2.4\text{ mg}$ per maintenance dose) Primary Indication Long-term weight management and chronic weight control Administration Route Subcutaneous injection (Once-weekly) Pack Composition Pre-filled multi-dose pens containing maintenance strengths Storage Requirements Refrigerate at $2^{\circ}\text{C}$ to $8^{\circ}\text{C}$ ($36^{\circ}\text{F}$ to $46^{\circ}\text{F}$) before first use
